Year: 2018
Type: article
Abstract: Optimal use of therapeutic monoclonal antibodies therapy requires an understanding of their mechanisms of action and how CLL cells resist these cytotoxic effects. This critical review details current knowledge and questions.
Source: Oncology Signaling
Author: Clive S. Zent
Institution: University of Rochester Medicine
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2892565005